Your session is about to expire
← Back to Search
BICX104 for Opioid Use Disorder
Study Summary
This trial is testing a new way to deliver naltrexone, a drug used to treat alcoholism, and comparing it to the current standard of care. The study will last 6 months and will involve people who do not have alcoholism.
- Opioid Use Disorder
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 2 trial • 29 Patients • NCT03008590Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Is the study actively seeking individuals aged eighty-five and older as participants?
"Enrolment in this trial is limited to those aged 18-50. By contrast, there are 25 trials that accept minors and 274 studies recruiting seniors over the age of 65."
Could you provide a synopsis of research conducted using BICX104?
"Currently, there are 46 active clinical studies being conducted on the effects of BICX104. Of those trials, 12 have reached Phase 3. This medication is widely tested in New york with 161 sites hosting related studies."
What is the maximum capacity for this medical trial?
"Affirmative. According to the details found on clinicaltrials.gov, this experiment was announced on June 17th 2022 and has recently been updated in July 18 of the same year. 24 volunteers are needed from one medical centre for enrollment in this trial."
What prerequisites must an individual satisfy to participate in this research endeavor?
"This clinical trial is open to 24 individuals aged 18-50 with an active opioid use disorder diagnosis. In order to join, participants must be willing and able to provide informed consent as well posses a BMI between 18.5 - 30 kg/m2 and weigh 100-180 pounds. Additionally, they cannot have any other substance abuse diagnoses (unless in sustained remission). Finally, both sexes are expected to practice reliable contraception methods over the course of their participation in this experiment (<1% failure rate per year)."
Has BICX104 received regulatory authorization from the FDA?
"The safety of BICX104 is provisionally estimated to be a score of 1, given the fact that this project is in its early stages with minimal evidence for efficacy and safety."
What are the common applications of BICX104?
"BICX104 is primarily used to manage weight. However, its applications range from promoting physical activity and managing pain to supporting reduced-calorie diets."
Is enrollment for this research program available at the moment?
"According to clinicaltrials.gov, this experiment is actively seeking participants and was last modified on July 18th 2022 since it's initial posting on June 17th 2022."
Share this study with friends
Copy Link
Messenger